Minocycline HCl SR Pellets Manufacturer in India

Minocycline HCl SR Pellets – Pharmaceutical-Grade Sustained-Release Pellets

Minocycline HCl SR Pellets are pharmaceutical-grade multiparticulate pellets containing Minocycline Hydrochloride and designed for sustained-release oral dosage-form development. The pellet format provides a flexible platform for capsule filling and other multiparticulate pharmaceutical formulations.

Minocycline Hydrochloride is identified by CAS Number 13614-98-7, with molecular formula C₂₃H₂₇N₃O₇·HCl and molecular weight 493.94 g/mol. A separate material, Minocycline Hydrochloride Dihydrate, is identified by CAS 128420-71-3 and should not be treated as identical to the anhydrous hydrochloride material.

Importantly for the SDP catalogue, the available SDP pellet product list specifies Minocycline HCl SR Pellets at 35% strength. Therefore, 35% can be included as the available SDP strength rather than using an unrelated market value.

Key Features

• Minocycline HCl SR Pellets
• 35% available strength
• Pharmaceutical Grade
• Sustained-release multiparticulate pellet format
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• Product-specific active-ingredient loading
• Controlled-release formulation platform
• Suitable for multiparticulate formulation development
• Product-specific particle-size and dissolution characteristics

Minocycline Hydrochloride Sustained-Release Pellets

Minocycline Hydrochloride SR Pellets provide a pellet-based formulation platform for pharmaceutical manufacturers developing sustained-release multiparticulate oral dosage forms.

The sustained-release characteristics depend on factors including active-ingredient loading, pellet size, excipient composition, release-controlling system, coating characteristics and manufacturing conditions. The 35% Minocycline HCl SR Pellets listed for SDP should therefore be presented as the available product strength, while other technical parameters should follow the applicable product specification.

Applications

Minocycline HCl SR Pellets can be considered for:

• Sustained-release capsule formulations
• Multiparticulate oral formulations
• Capsule filling
• Controlled-release formulation development
• Oral dosage-form development
• Pellet-based pharmaceutical formulations
• Multiparticulate formulation research
• Bulk pharmaceutical manufacturing requirements

Manufacturing & Processing

Minocycline HCl SR Pellets may be manufactured using suitable pelletization, layering and functional-coating technologies.

Important product parameters can include:

• 35% active-ingredient loading
• Pellet-size distribution
• Assay
• Moisture content
• Content uniformity
• Pellet morphology
• Mechanical strength
• Friability
• Coating characteristics
• Dissolution profile
• Sustained-release performance

The final acceptance criteria should be established through the validated Minocycline HCl SR Pellets product specification.

Quality & Testing

Minocycline HCl SR Pellets may be evaluated for:

• Identification by HPLC / suitable analytical technique
• Assay by HPLC
• Related substances
• Loss on drying
• Water content
• Residue on ignition where applicable
• Particle-size distribution
• Pellet morphology
• Mechanical strength / friability
• Content uniformity
• Dissolution testing
• Sustained-release profile
• Coating uniformity where applicable

Particular analytical attention may be required for Minocycline-related impurities and degradation products. The finished-pellet acceptance limits should follow the applicable validated product specification.

Why Minocycline HCl SR Pellets from Swapnroop?

Minocycline HCl SR Pellets from Swapnroop are positioned as pharmaceutical-grade multiparticulate pellets for sustained-release formulation development and capsule-filling applications.

• 35% Available Strength – SDP's product list identifies Minocycline HCl SR Pellets at 35%. 
• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Sustained-Release Format – Developed for formulations requiring a controlled release profile.
• Product-Specific Loading – The available 35% formulation provides a defined active-ingredient loading.
• Multiparticulate Formulation – Suitable for capsule filling and oral dosage-form development.
• Controlled Quality Parameters – Assay, moisture, particle size and dissolution can be evaluated according to the applicable specification.
• Formulation Flexibility – Pellet characteristics can be established according to formulation requirements.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical formulation and manufacturing requirements.

Packaging & Bulk Supply

Minocycline HCl SR Pellets can be supplied in suitable pharmaceutical bulk packaging according to the applicable product specification. The available 35% strength should be clearly identified in commercial and technical documentation.

Get Bulk Quote via WhatsApp